|
NAT10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.14499999773699E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.40230000009478E-07 |
| Normal-vs-Stage2 |
7.799300E-03 |
| Normal-vs-Stage3 |
1.423290E-04 |
| Normal-vs-Stage4 |
6.4730999999929E-05 |
| Stage1-vs-Stage2 |
3.594400E-01 |
| Stage1-vs-Stage3 |
5.182600E-01 |
| Stage1-vs-Stage4 |
7.165200E-01 |
| Stage2-vs-Stage3 |
7.603400E-01 |
| Stage2-vs-Stage4 |
3.666600E-01 |
| Stage3-vs-Stage4 |
4.370000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.28199999797019E-08 |
| Normal-vs-AfricanAmerican |
2.457600E-03 |
| Normal-vs-Asian |
1.250230E-02 |
| Caucasian-vs-AfricanAmerican |
4.006600E-01 |
| Caucasian-vs-Asian |
6.964600E-01 |
| AfricanAmerican-vs-Asian |
4.244400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.92479999997042E-06 |
| Normal-vs-Female |
4.17860002155379E-09 |
| Male-vs-Female |
3.843900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.305700E-02 |
| Normal-vs-Age(41-60Yrs) |
4.24380000030311E-07 |
| Normal-vs-Age(61-80Yrs) |
2.15080000032231E-07 |
| Normal-vs-Age(81-100Yrs) |
8.237700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.160200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.676600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.812200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.023600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.978000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.379600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.16729999996868E-06 |
| Normal-vs-Grade 2 |
4.70359999948933E-07 |
| Normal-vs-Grade 3 |
1.41119999996775E-06 |
| Normal-vs-Grade 4 |
3.787800E-04 |
| Grade 1-vs-Grade 2 |
8.223800E-02 |
| Grade 1-vs-Grade 3 |
7.624100E-02 |
| Grade 1-vs-Grade 4 |
6.285800E-02 |
| Grade 2-vs-Grade 3 |
8.655800E-01 |
| Grade 2-vs-Grade 4 |
8.119400E-01 |
| Grade 3-vs-Grade 4 |
7.351800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.16780038364561E-10 |
| Normal-vs-ccB subtype |
3.588400E-04 |
| ccA subtype-vs-ccB subtype |
2.662200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.74880000001355E-07 |
| Normal-vs-N1 |
1.973930E-02 |
| N0-vs-N1 |
9.333400E-01 |
|
|
